Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and …
MB Dolovich, RC Ahrens, DR Hess, P Anderson… - Chest, 2005 - Elsevier
Background The proliferation of inhaler devices has resulted in a confusing number of
choices for clinicians who are selecting a delivery device for aerosol therapy. There are …
choices for clinicians who are selecting a delivery device for aerosol therapy. There are …
Medication adherence issues in patients treated for COPD
RD Restrepo, MT Alvarez, LD Wittnebel… - … journal of chronic …, 2008 - Taylor & Francis
Although medical treatment of COPD has advanced, nonadherence to medication regimens
poses a significant barrier to optimal management. Underuse, overuse, and improper use …
poses a significant barrier to optimal management. Underuse, overuse, and improper use …
Practical problems with aerosol therapy in COPD
JL Rau - Respiratory care, 2006 - rc.rcjournal.com
Inhaled aerosol drugs commonly used by patients with chronic obstructive pulmonary
disease include short-acting and long-acting bronchodilators, as well as corticosteroids …
disease include short-acting and long-acting bronchodilators, as well as corticosteroids …
Inhaler device selection: special considerations in elderly patients with chronic obstructive pulmonary disease
R Barrons, A Pegram, A Borries - American Journal of Health …, 2011 - academic.oup.com
Purpose Special considerations in the selection of medication inhaler devices for elderly
patients with chronic obstructive pulmonary disease (COPD) in the ambulatory care setting …
patients with chronic obstructive pulmonary disease (COPD) in the ambulatory care setting …
Optimising inhaled pharmacotherapy for elderly patients with chronic obstructive pulmonary disease: the importance of delivery devices
F Lavorini, C Mannini, E Chellini, GA Fontana - Drugs & aging, 2016 - Springer
Chronic obstructive pulmonary disease (COPD) is common in older people. Inhaled
medications are the mainstay of pharmacological treatment of COPD, and are typically …
medications are the mainstay of pharmacological treatment of COPD, and are typically …
Development and validation of a patient satisfaction and preference questionnaire for inhalation devices
CM Kozma, TL Slaton, BU Monz, R Hodder… - Treatments in respiratory …, 2005 - Springer
Abstract Introduction The Patient Satisfaction and Preference Questionnaire (PASAPQ) is a
multi-item measure of respiratory inhalation device satisfaction and preference designed to …
multi-item measure of respiratory inhalation device satisfaction and preference designed to …
Inhaler devices for patients with COPD
JB Fink, GL Colice, R Hodder - COPD: Journal of Chronic …, 2013 - Taylor & Francis
Chronic obstructive pulmonary disease (COPD) continues to be associated with increased
morbidity and mortality risk in spite of updated guidelines and a better understanding of this …
morbidity and mortality risk in spite of updated guidelines and a better understanding of this …
Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
MP Pieper, CJM Meade, M Pairet - US Patent 7,244,742, 2007 - Google Patents
US7244742B2 - Pharmaceutical compositions for inhalation containing an anticholinergic,
corticosteroid and betamimetic - Google Patents US7244742B2 - Pharmaceutical …
corticosteroid and betamimetic - Google Patents US7244742B2 - Pharmaceutical …
Factors to consider when selecting a nebulizer for a new inhaled drug product development program
M Elphick, D von Hollen, JN Pritchard… - Expert opinion on …, 2015 - Taylor & Francis
Introduction: Nebulizers are a common device choice for use when developing a new drug
product, but the range of nebulizer devices available can make it difficult to select the right …
product, but the range of nebulizer devices available can make it difficult to select the right …
Inhalable formulation of a solution containing a tiotropium salt
K Drechsel, B Niklaus-Humke, C Schmelzer… - US Patent …, 2005 - Google Patents
4,042,700 A 8/1977 Banholzer et al. 4,608.377 A 8/1986 Banholzer et al. 4,783,534 A
11/1988 Banholzer et al. 5,610,163 A 3/1997 Banholzer et al. 5,654,314 A 8/1997 Banholzer …
11/1988 Banholzer et al. 5,610,163 A 3/1997 Banholzer et al. 5,654,314 A 8/1997 Banholzer …